About Maiva Pharma
Maiva Pharma is a company based in Hosur (India) founded in 1996.. Maiva Pharma has raised $124.83 million across 7 funding rounds from investors including Morgan Stanley, PharmaScience and Mahaganapati Advisors. The company has 751 employees as of April 03, 2024. Maiva Pharma offers products and services including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study. Maiva Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hosur, India
- Employees 751 as on 03 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Maiva Pharma Private Limited
- Date of Incorporation 05 Feb, 1993
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$25.52 M (USD)0as on Mar 31, 2023
-
Net Profit
$4.38 M (USD)0as on Mar 31, 2023
-
EBITDA
$6.95 M (USD)0as on Mar 31, 2023
-
Total Equity Funding
$124.83 M (USD)
in 7 rounds
-
Latest Funding Round
$119.8 M (USD), Unspecified
Apr 30, 2024
-
Investors
Morgan Stanley
& 8 more
-
Employee Count
751
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Maiva Pharma
Maiva Pharma offers a comprehensive portfolio of products and services, including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactures sterile liquid pharmaceuticals for medical use.
Produces freeze-dried pharmaceutical products for stability.
Conducts studies to assess material safety in pharmaceuticals.
Evaluates container integrity for pharmaceutical applications.
Analyzes impurities to meet pharmaceutical standards.
Unlock access to complete
Leadership Team
2 people
Lead Team
1 people
Assistant Team
1 people
Senior Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Maiva Pharma
Maiva Pharma has successfully raised a total of $124.83M across 7 strategic funding rounds. The most recent funding activity was a Unspecified round of $119.8 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Unspecified — $119.8M
-
First Round
First Round
(06 Oct 2009)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Unspecified - Maiva Pharma | Valuation | InvAscent , Nhpea V Spear | |
| Mar, 2016 | Amount | Unspecified - Maiva Pharma | Valuation |
investors |
|
| Feb, 2016 | Amount | Unspecified - Maiva Pharma | Valuation | Mahaganapati Advisors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Maiva Pharma
Maiva Pharma has secured backing from 9 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Morgan Stanley, PharmaScience and Mahaganapati Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Founded Year | Domain | Location | |
|
Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets.
|
Founded Year | Domain | Location | |
|
Business advisory consulting services are provided to various clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Maiva Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Maiva Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Maiva Pharma Comparisons
Competitors of Maiva Pharma
Maiva Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Maiva Pharma
Frequently Asked Questions about Maiva Pharma
When was Maiva Pharma founded?
Maiva Pharma was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Where is Maiva Pharma located?
Maiva Pharma is headquartered in Hosur, India. It is registered at Hosur, Tamil Nadu, India.
Who is the current CEO of Maiva Pharma?
Bhaskar Krishna Arumugam is the current CEO of Maiva Pharma.
Is Maiva Pharma a funded company?
Maiva Pharma is a funded company, having raised a total of $124.83M across 7 funding rounds to date. The company's 1st funding round was a Unspecified of $174.85K, raised on Oct 06, 2009.
How many employees does Maiva Pharma have?
As of Apr 03, 2024, the latest employee count at Maiva Pharma is 751.
What is the annual revenue of Maiva Pharma?
Annual revenue of Maiva Pharma is $25.52M as on Mar 31, 2023.
What does Maiva Pharma do?
Maiva Pharma was founded in 1996 and is based in Hosur, India. Operations focus on the pharmaceutical sector, where formulation development and analytical method validation services are offered. Injectable supply services are also managed to support manufacturing needs. The company serves clients through these core activities in a specialized environment.
Who are the top competitors of Maiva Pharma?
Maiva Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Maiva Pharma offer?
Maiva Pharma offers Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study.
Who are Maiva Pharma's investors?
Maiva Pharma has 9 investors. Key investors include Morgan Stanley, PharmaScience, Mahaganapati Advisors, Anna Thomas Chacko, and T Thomas.
What is Maiva Pharma's valuation?
The valuation of Maiva Pharma is $13.6M as of Mar 2016.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.